The world's best businesses are not always in the S&P 500. Many of the most durable compounders (strong moats, disciplined capital allocators, decades of reinvestment runway) are listed on exchanges that institutional capital structurally cannot access at scale.
Position sizes are too small. Markets are too illiquid. A fund managing billions cannot move the needle by investing in a €50m company. When large pools of capital cannot participate, nobody produces research. When nobody produces research, the market cannot price the business correctly.
Sifter Research publishes free, complete equity research on these companies. Every report is built from primary sources, across languages and jurisdictions. Three explicit valuation scenarios. The author's name on every judgment call. Nothing anonymous. Nothing hedged into uselessness.
Every company passes the same framework before any valuation begins. The checklist draws on the principles of Graham, Buffett, Munger, Pabrai and Li Lu. Refined over a decade of studying what separates long-term compounders from value traps.
Over the years, I've spent a lot of time on investment platforms, forums, newsletters and communities. Great ideas everywhere: tickers, theses, one-liners that make you think. But I always had the same problem: when I find something interesting, I still have to do all the research myself. Every time.
I looked for research that was actually complete, a real deep-dive where you can follow the reasoning, check the numbers and disagree with the conclusion if you want. Rarely found it. Especially on small-caps, where institutional coverage is thin and mispricing opportunities are real. So I built it myself.
See our published research →